ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene-based Advanced Therapy Medical Product Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38Y14028
Home | Market Reports | Health| Pharmacy
Global Gene based Advanced Therapy Medical Product Market Research Report 2023
BUY CHAPTERS

Global Gene-based Advanced Therapy Medical Product Market Research Report 2025

Code: QYRE-Auto-38Y14028
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Spark Therapeutics
Akcea Therapeutics
Bluebird bio
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Gene-based Advanced Therapy Medical Product Market Size

The global market for Gene-based Advanced Therapy Medical Product was valued at US$ 13690 million in the year 2024 and is projected to reach a revised size of US$ 48640 million by 2031, growing at a CAGR of 20.2% during the forecast period.

Gene-based Advanced Therapy Medical Product Market

Gene-based Advanced Therapy Medical Product Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
This report aims to provide a comprehensive presentation of the global market for Gene-based Advanced Therapy Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene-based Advanced Therapy Medical Product.
The Gene-based Advanced Therapy Medical Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene-based Advanced Therapy Medical Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene-based Advanced Therapy Medical Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene-based Advanced Therapy Medical Product Market Report

Report Metric Details
Report Name Gene-based Advanced Therapy Medical Product Market
Accounted market size in year US$ 13690 million
Forecasted market size in 2031 US$ 48640 million
CAGR 20.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene-based Advanced Therapy Medical Product company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene-based Advanced Therapy Medical Product Market growing?

Ans: The Gene-based Advanced Therapy Medical Product Market witnessing a CAGR of 20.2% during the forecast period 2025-2031.

What is the Gene-based Advanced Therapy Medical Product Market size in 2031?

Ans: The Gene-based Advanced Therapy Medical Product Market size in 2031 will be US$ 48640 million.

Who are the main players in the Gene-based Advanced Therapy Medical Product Market report?

Ans: The main players in the Gene-based Advanced Therapy Medical Product Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene-based Advanced Therapy Medical Product Market report?

Ans: The Applications covered in the Gene-based Advanced Therapy Medical Product Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene-based Advanced Therapy Medical Product Market report?

Ans: The Types covered in the Gene-based Advanced Therapy Medical Product Market report are Viral Gene Delivery System, Non-viral Gene Delivery System

Recommended Reports

Gene Therapy Markets

Gene & Cell Solutions

Specialized Gene Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene-based Advanced Therapy Medical Product Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene-based Advanced Therapy Medical Product Market Perspective (2020-2031)
2.2 Global Gene-based Advanced Therapy Medical Product Growth Trends by Region
2.2.1 Global Gene-based Advanced Therapy Medical Product Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene-based Advanced Therapy Medical Product Historic Market Size by Region (2020-2025)
2.2.3 Gene-based Advanced Therapy Medical Product Forecasted Market Size by Region (2026-2031)
2.3 Gene-based Advanced Therapy Medical Product Market Dynamics
2.3.1 Gene-based Advanced Therapy Medical Product Industry Trends
2.3.2 Gene-based Advanced Therapy Medical Product Market Drivers
2.3.3 Gene-based Advanced Therapy Medical Product Market Challenges
2.3.4 Gene-based Advanced Therapy Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue
3.1.1 Global Top Gene-based Advanced Therapy Medical Product Players by Revenue (2020-2025)
3.1.2 Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Players (2020-2025)
3.2 Global Gene-based Advanced Therapy Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene-based Advanced Therapy Medical Product Revenue
3.4 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio
3.4.1 Global Gene-based Advanced Therapy Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene-based Advanced Therapy Medical Product Revenue in 2024
3.5 Global Key Players of Gene-based Advanced Therapy Medical Product Head office and Area Served
3.6 Global Key Players of Gene-based Advanced Therapy Medical Product, Product and Application
3.7 Global Key Players of Gene-based Advanced Therapy Medical Product, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene-based Advanced Therapy Medical Product Breakdown Data by Type
4.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Type (2020-2025)
4.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Type (2026-2031)
5 Gene-based Advanced Therapy Medical Product Breakdown Data by Application
5.1 Global Gene-based Advanced Therapy Medical Product Historic Market Size by Application (2020-2025)
5.2 Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene-based Advanced Therapy Medical Product Market Size (2020-2031)
6.2 North America Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025)
6.4 North America Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene-based Advanced Therapy Medical Product Market Size (2020-2031)
7.2 Europe Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025)
7.4 Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size (2020-2031)
8.2 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene-based Advanced Therapy Medical Product Market Size (2020-2031)
9.2 Latin America Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025)
9.4 Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size (2020-2031)
10.2 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene-based Advanced Therapy Medical Product Introduction
11.1.4 Biogen Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene-based Advanced Therapy Medical Product Introduction
11.2.4 Novartis Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medical Product Introduction
11.3.4 Gilead Sciences Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene-based Advanced Therapy Medical Product Introduction
11.6.4 Amgen Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.7.4 Spark Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.8.4 Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene-based Advanced Therapy Medical Product Introduction
11.9.4 bluebird bio Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene-based Advanced Therapy Medical Product Introduction
11.10.4 Sunway Biotech Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene-based Advanced Therapy Medical Product Introduction
11.11.4 SIBIONO Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene-based Advanced Therapy Medical Product Introduction
11.12.4 AnGes Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene-based Advanced Therapy Medical Product Introduction
11.13.4 Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen Inc
Spark Therapeutics
Akcea Therapeutics
Bluebird bio
Sunway Biotech
Sibiono
AnGes
Orchard Therapeutics
Human Stem Cells Institute
List of Tables
 Table 1. Global Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Viral Gene Delivery System
 Table 3. Key Players of Non-viral Gene Delivery System
 Table 4. Global Gene-based Advanced Therapy Medical Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Gene-based Advanced Therapy Medical Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gene-based Advanced Therapy Medical Product Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2020-2025)
 Table 8. Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Gene-based Advanced Therapy Medical Product Market Share by Region (2026-2031)
 Table 10. Gene-based Advanced Therapy Medical Product Market Trends
 Table 11. Gene-based Advanced Therapy Medical Product Market Drivers
 Table 12. Gene-based Advanced Therapy Medical Product Market Challenges
 Table 13. Gene-based Advanced Therapy Medical Product Market Restraints
 Table 14. Global Gene-based Advanced Therapy Medical Product Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Gene-based Advanced Therapy Medical Product Market Share by Players (2020-2025)
 Table 16. Global Top Gene-based Advanced Therapy Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Advanced Therapy Medical Product as of 2024)
 Table 17. Ranking of Global Top Gene-based Advanced Therapy Medical Product Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Gene-based Advanced Therapy Medical Product Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Gene-based Advanced Therapy Medical Product, Headquarters and Area Served
 Table 20. Global Key Players of Gene-based Advanced Therapy Medical Product, Product and Application
 Table 21. Global Key Players of Gene-based Advanced Therapy Medical Product, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Gene-based Advanced Therapy Medical Product Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Type (2020-2025)
 Table 25. Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Type (2026-2031)
 Table 27. Global Gene-based Advanced Therapy Medical Product Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Application (2020-2025)
 Table 29. Global Gene-based Advanced Therapy Medical Product Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Gene-based Advanced Therapy Medical Product Revenue Market Share by Application (2026-2031)
 Table 31. North America Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Biogen Company Details
 Table 47. Biogen Business Overview
 Table 48. Biogen Gene-based Advanced Therapy Medical Product Product
 Table 49. Biogen Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 50. Biogen Recent Development
 Table 51. Novartis Company Details
 Table 52. Novartis Business Overview
 Table 53. Novartis Gene-based Advanced Therapy Medical Product Product
 Table 54. Novartis Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 55. Novartis Recent Development
 Table 56. Gilead Sciences Company Details
 Table 57. Gilead Sciences Business Overview
 Table 58. Gilead Sciences Gene-based Advanced Therapy Medical Product Product
 Table 59. Gilead Sciences Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 60. Gilead Sciences Recent Development
 Table 61. Sarepta Therapeutics Company Details
 Table 62. Sarepta Therapeutics Business Overview
 Table 63. Sarepta Therapeutics Gene-based Advanced Therapy Medical Product Product
 Table 64. Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 65. Sarepta Therapeutics Recent Development
 Table 66. Alnylam Pharmaceuticals Company Details
 Table 67. Alnylam Pharmaceuticals Business Overview
 Table 68. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medical Product Product
 Table 69. Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 70. Alnylam Pharmaceuticals Recent Development
 Table 71. Amgen Company Details
 Table 72. Amgen Business Overview
 Table 73. Amgen Gene-based Advanced Therapy Medical Product Product
 Table 74. Amgen Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 75. Amgen Recent Development
 Table 76. Spark Therapeutics Company Details
 Table 77. Spark Therapeutics Business Overview
 Table 78. Spark Therapeutics Gene-based Advanced Therapy Medical Product Product
 Table 79. Spark Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 80. Spark Therapeutics Recent Development
 Table 81. Akcea Therapeutics Company Details
 Table 82. Akcea Therapeutics Business Overview
 Table 83. Akcea Therapeutics Gene-based Advanced Therapy Medical Product Product
 Table 84. Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 85. Akcea Therapeutics Recent Development
 Table 86. bluebird bio Company Details
 Table 87. bluebird bio Business Overview
 Table 88. bluebird bio Gene-based Advanced Therapy Medical Product Product
 Table 89. bluebird bio Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 90. bluebird bio Recent Development
 Table 91. Sunway Biotech Company Details
 Table 92. Sunway Biotech Business Overview
 Table 93. Sunway Biotech Gene-based Advanced Therapy Medical Product Product
 Table 94. Sunway Biotech Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 95. Sunway Biotech Recent Development
 Table 96. SIBIONO Company Details
 Table 97. SIBIONO Business Overview
 Table 98. SIBIONO Gene-based Advanced Therapy Medical Product Product
 Table 99. SIBIONO Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 100. SIBIONO Recent Development
 Table 101. AnGes Company Details
 Table 102. AnGes Business Overview
 Table 103. AnGes Gene-based Advanced Therapy Medical Product Product
 Table 104. AnGes Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 105. AnGes Recent Development
 Table 106. Orchard Therapeutics Company Details
 Table 107. Orchard Therapeutics Business Overview
 Table 108. Orchard Therapeutics Gene-based Advanced Therapy Medical Product Product
 Table 109. Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 110. Orchard Therapeutics Recent Development
 Table 111. Human Stem Cells Institute Company Details
 Table 112. Human Stem Cells Institute Business Overview
 Table 113. Human Stem Cells Institute Gene-based Advanced Therapy Medical Product Product
 Table 114. Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medical Product Business (2020-2025) & (US$ Million)
 Table 115. Human Stem Cells Institute Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Gene-based Advanced Therapy Medical Product Picture
 Figure 2. Global Gene-based Advanced Therapy Medical Product Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene-based Advanced Therapy Medical Product Market Share by Type: 2024 VS 2031
 Figure 4. Viral Gene Delivery System Features
 Figure 5. Non-viral Gene Delivery System Features
 Figure 6. Global Gene-based Advanced Therapy Medical Product Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gene-based Advanced Therapy Medical Product Market Share by Application: 2024 VS 2031
 Figure 8. Neurological Diseases Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Other Case Studies
 Figure 11. Gene-based Advanced Therapy Medical Product Report Years Considered
 Figure 12. Global Gene-based Advanced Therapy Medical Product Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Gene-based Advanced Therapy Medical Product Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gene-based Advanced Therapy Medical Product Market Share by Region: 2024 VS 2031
 Figure 15. Global Gene-based Advanced Therapy Medical Product Market Share by Players in 2024
 Figure 16. Global Top Gene-based Advanced Therapy Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Advanced Therapy Medical Product as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Gene-based Advanced Therapy Medical Product Revenue in 2024
 Figure 18. North America Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Gene-based Advanced Therapy Medical Product Market Share by Country (2020-2031)
 Figure 20. United States Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Gene-based Advanced Therapy Medical Product Market Share by Country (2020-2031)
 Figure 24. Germany Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Gene-based Advanced Therapy Medical Product Market Share by Region (2020-2031)
 Figure 32. China Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Gene-based Advanced Therapy Medical Product Market Share by Country (2020-2031)
 Figure 40. Mexico Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Gene-based Advanced Therapy Medical Product Market Share by Country (2020-2031)
 Figure 44. Turkey Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Gene-based Advanced Therapy Medical Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Biogen Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 48. Novartis Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 49. Gilead Sciences Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 52. Amgen Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 53. Spark Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 55. bluebird bio Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 56. Sunway Biotech Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 57. SIBIONO Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 58. AnGes Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 59. Orchard Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 60. Human Stem Cells Institute Revenue Growth Rate in Gene-based Advanced Therapy Medical Product Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene based Advanced Therapy Medicinal Market Research Report 2025
Global Advanced Therapy Based on Gene Market Research Report 2025
Global Gene based Therapy Medicinal Market Research Report 2024
Global DNA Medicine Based on DNA Modification Market Research Report 2025
Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Gene Therapy Market Research Report 2025
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Gene Delivery or Gene Therapy Drug Market Research Report 2025
Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Gene Therapy On Cardiovascular Disease Market Research Report 2025
Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Global Cell and Gene Therapy Market Research Report 2024
Global Gene Therapy For Cancer Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions